Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
The Trade Desk arrives at its October 19 earnings report with options traders at their most aggressively bullish in a year, a $12 stock facing a Street that has been slashing targets, and a short position covering nearly a fifth of the free float that has barely budged despite five weeks of steady erosion. Five days from the print, the signals are pulling in opposite directions.
The clearest anomaly is in the options market. Demand for calls is overwhelming demand for puts by a historically unusual margin: the put/call ratio is 0.31, its lowest reading of the past year and almost 1.8 standard deviations below the 20-day average of 0.35. That is the most one-sided bullish options setup TTD has seen in at least twelve months. Call buyers at the 52-week low of the PCR are betting on recovery even as the fundamental picture has deteriorated sharply. It is worth noting that the borrow market offers no sign of a forced squeeze driving this: availability is extremely loose at roughly 1,620%, meaning for every share currently lent out there are more than sixteen available to borrow. Cost to borrow has ticked up 37% on the week to 0.53%, but remains trivially cheap. The options positioning is conviction, not mechanics.
Short interest reinforces how entrenched the bear side remains, despite slowly losing ground. Shorts hold 18.8% of the free float, representing around 82.7 million shares. That figure has come down gradually from a peak near 89 million shares in mid-September, falling roughly 7.5 million shares over five weeks. The pace is measured rather than urgent, and the ORTEX short score of 52.8 places TTD near the median of the universe. Days to cover on the FINRA fortnightly settlement stands at 2.6 days. Bears are trimming, but they are not fleeing ahead of earnings.
The Street itself is an uncomfortable backdrop for both sides. The consensus mean price target is $13.53 against a close of $12.17, a gap that looks narrow rather than aspirational given the scale of recent estimate cuts. UBS, which still carries a Buy rating, lowered its target to $15 from $16 on October 14, the session before this note. That follows a wave of post-August-earnings damage: Citigroup downgraded to Sell with an $11 target, DA Davidson moved to Neutral from Buy, and HSBC cut to Reduce. The bull case, per Benzinga, rests on CTV and international growth, the Publicis relationship recovery, and roughly $150 million in cost savings from the 15% workforce reduction flowing through to 2027 EBITDA. The bear case is harder to dismiss: revenue growth has gone from 27% in Q3 2024 to a 12% year-on-year decline implied by Q3 2026 guidance of $650 million, three CFOs since January, and a CRO gone after seven months. Factor scores reflect the damage: EPS momentum over the past 30 days ranks in the 21st percentile of the universe, and the 90-day reading is in the 7th. Forward EPS growth on a 12-month basis ranks in the 95th percentile, which is the one data point bulls cling to as a recovery signal.
The ownership picture has shifted materially since the index removal, and that context remains live. BlackRock raised its stake to 11.4% in a 13G amendment filed October 5, making it the largest institutional holder. State Street trimmed from 10.4% to 3.3% in a filing dated October 7, a move consistent with index-rebalancing mechanics following TTD's removal from the S&P 500 and addition to the S&P SmallCap 600, both effective September 21. As noted in the October 10 article here, that mechanical reshuffling is complete, but its effects on the shareholder register are still being absorbed. CEO Jeffrey Green holds 11.3% of shares per his May 2026 13G filing. The September 14 grants of stock to the CFO, COO, and CLO are compensation awards rather than open-market purchases, so they carry limited signal on insider conviction ahead of the print.
The earnings history strips away any ambiguity about the risk size. The last substantive print, in August 2026, saw the stock fall 27% on the day and 23% over the following five days. The prior quarter's earnings produced a 24% one-day drop. That reaction record is the essential context for the call-heavy options positioning: either options traders are making a high-conviction recovery bet into a historically punishing earnings pattern, or the positioning will prove to be the wrong side of a very large move. What to watch on October 19 is whether Q3 revenue comes in above or below the $650 million guidance figure, and whether management's commentary on Q4 shifts the narrative on whether the growth trajectory has found a floor.
See the live data behind this article on ORTEX.
Open TTD on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
